U.S. Retail REITs Stock News

Dorchester Minerals, L.P. recently entered into a non-taxable contribution and exchange agreement to acquire approximately 3,100 net royalty acres across five North Dakota counties in the Williston Basin, with the contributing entities receiving 850,000 common units and cash flows from April 1, 2026, onward being passed to the Partnership at closing. This acreage-for-units transaction meaningfully enlarges Dorchester Minerals’ royalty footprint in a key U.S. oil-producing region, potentially...

AI now accounts for over 25% of U.S. GDP growth and around 8% of total GDP, so your portfolio is increasingly tied to how this single theme plays out. The heavy spending by major tech companies on AI infrastructure could support companies that use artificial intelligence and automation to improve productivity, but it also concentrates risk if that spending slows. This article looks at 3 stocks from the AI-Enabled Productivity Leaders screener that are exposed to this AI investment wave and...

FedEx Corp. recently completed pricing and early settlement of cash tender offers to repurchase up to US$4.15 billion of long-dated notes, ultimately accepting about US$4.86 billion in aggregate principal using a waterfall priority system and early tender premiums. This debt buyback, funded in part by a US$4.10 billion dividend from the spun-off FedEx Freight business, sheds light on how management is reshaping the balance sheet and capital allocation plans after the separation. Next, we’ll...

Recently, Fanatec announced a new licensing partnership with Nissan Motor Co., Ltd. to develop officially licensed sim racing steering wheels that emphasize craftsmanship, ergonomic precision, and visual authenticity, while analysts downgraded Corsair Gaming on concerns about valuation, consumer demand, memory markets, and weaker global PC shipment forecasts. This combination of an expanded premium sim racing offering via Fanatec and fresh questions about Corsair’s valuation frame a contrast...

Board appointment and flu vaccine decision put Moderna in focus Interest in Moderna (MRNA) is being driven by an upcoming regulatory decision on its mRNA-1010 seasonal flu vaccine, alongside boardroom changes that refresh financial oversight and governance at the company. Against that backdrop, Moderna stock has been volatile, including an 11% pullback after a recent rally, as investors weigh the potential impact of an expanded pipeline in oncology and respiratory vaccines. See our latest...

Earlier this week, GitLab reported quarterly results that exceeded expectations but issued softer fiscal 2027 revenue and earnings guidance, highlighting a projected moderation in revenue growth and a decline in non-GAAP EPS despite rolling out its AI-driven Duo Agent Platform and authorizing a US$400 million share repurchase. The update underscores a tension between GitLab’s longer-term AI and platform ambitions and management’s cautious near-term outlook for monetization and...

In early July 2026, law firms The Schall Law Firm and Robbins Geller Rudman & Dowd LLP began investigating GPGI, Inc. for potential violations of U.S. federal securities laws related to its sustainable injection molding business. The convergence of several securities law investigations raises questions about GPGI’s disclosure practices and potential legal exposure, which could influence how investors assess its risk profile. Against this backdrop of fraud-related legal scrutiny, we’ll now...

In recent months, GATX Corporation reinforced its rail-leasing platform, maintaining 98.1% Rail North America fleet utilization while integrating the acquired Wells Fargo rail operating lease portfolio, and Fitch affirmed its BBB+/F2 ratings with a Stable Outlook, underscoring balance-sheet strength. This combination of high utilization, firm lease pricing and a ratings affirmation highlights the resilience of GATX’s core rail-leasing franchise and financing capacity. Next, we will examine...

Suzhou Ribo Life Science Co. Ltd. recently announced that its siRNA partnership with Madrigal Pharmaceuticals achieved a first candidate drug nomination for RNA-based liver disease therapeutics targeting metabolic dysfunction-associated steatohepatitis (MASH), enabling the start of IND-enabling studies. This early-stage milestone underscores Madrigal’s push beyond its current MASH franchise, tapping a liver-targeted RNA platform aimed at a very large global patient population with limited...

SoundHound AI stock has nearly doubled over the past three years, yet the broader valuation checks currently lean expensive. This raises questions about how much of its voice and agentic AI story is already reflected in the US$6.64 share price. Over the last three years, SoundHound AI has delivered a return of 91.4%, which puts recent share price weakness into the context of a much stronger longer term run. Expansion of its conversational and agentic AI platform into areas like restaurants,...

With inflation signals mixed across regions and central banks weighing their next moves, many investors are looking for companies where analysts still see clear earnings growth potential and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener is designed to highlight. It focuses on stocks where analysts expect strong earnings growth over the next 3 years along with acceptable financial strength. In this article, you will see 3 of...

Snap (SNAP) is back in the spotlight after launching its high priced SPECS augmented reality glasses, a hardware push that lands just as the stock shows weakness and underlying cash generation looks more efficient. See our latest analysis for Snap. Despite the excitement around SPECS, Snap’s share price return has been weak, with the stock down 11.03% over the past 30 days and the year to date share price return down 42.44%, while the 1 year total shareholder return has fallen 48.63% and the...

Wynn Resorts has recently drawn strong options interest while highlighting its upcoming Wynn Al Marjan Island integrated resort in Ras Al Khaimah, UAE, scheduled to open in 2027 as its entry into the Middle East market. The project’s blend of luxury hospitality, entertainment, and regional cultural references underlines Wynn’s effort to broaden its global footprint beyond its existing core destinations. We’ll now examine how Wynn’s planned Al Marjan Island entry into the Middle East could...

Earlier this month, Prologis, Inc. announced that its board appointed Alfred F. Kelly, Jr., former Visa CEO and current Berkshire Partners advisory director, to serve as a company director and member of the Board Governance and Nomination Committee. The addition of Kelly, who also sits on General Motors’ Audit and Risk & Cybersecurity Committees, coincides with heightened attention on Prologis’ global logistics footprint and potential international expansion deals, including speculation...

High profile turmoil at Bolt Financial, from collapsing valuation to headline grabbing HR cuts, has thrown a harsh light on how companies manage people risk. For investors, it underlines that culture, workforce structure, and leadership behaviour can be just as material as revenue lines or P/E ratios. This article uses our Human Capital Management and HR Technology screener to spotlight 3 stocks that are exposed to the same themes, but in very different ways. You will see how their tools and...

U.S. Physical Therapy (USPH) has come onto investors’ radar after recent trading, with the stock moving in both directions over the past month and over the past 3 months, prompting closer attention to its fundamentals. See our latest analysis for U.S. Physical Therapy. At a share price of $72.54, U.S. Physical Therapy has seen its 30 day share price return rise 10.65%, while the year to date share price return is down 8.04% and the 3 year total shareholder return is down 35.50%. This points...

In early 2026, ADMA Biologics was accused of inflating reported revenue growth through alleged channel stuffing and undisclosed related-party dealings, prompting securities fraud class action filings and multiple law firm investigations that the company disputes. The wave of legal actions has put ADMA’s financial reporting practices and internal controls under intense scrutiny, raising fresh questions about the reliability of its previously reported growth drivers. We’ll now examine how...

Avery Dennison (AVY) has attracted fresh attention after recent share price moves, as investors weigh mixed returns and a widely discussed fair value estimate of about $200 against the current $160.71 level. See our latest analysis for Avery Dennison. The recent 1 day share price gain of 1.03% has not yet offset weaker momentum, with the 90 day share price return down 6.68% and the 1 year total shareholder return down 9.80%, suggesting interest in Avery Dennison is being tempered even as...

Salesforce (CRM) is back in the spotlight after the U.S. Air Force’s 441st Vehicle Support Chain Operations Squadron selected its Missionforce National Security platform to manage a US$13.5b fleet across 84,000 vehicles. See our latest analysis for Salesforce. Despite this contract win, Salesforce’s share price remains under pressure, with the year to date share price return down 35.6% and the 1 year total shareholder return down 36.2%. This suggests that recent negative sentiment has...

Apple stock has delivered strong gains over the past five years, yet the valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium price while earnings based multiples screen the shares as cheaper relative to peers. Apple has returned 121.0% over 5 years, which puts extra focus on whether today's price still leaves enough room for future cash flow assumptions to play out. On the one hand, long term product and chip partnerships such as...

Earlier this month, Meta Platforms reshaped its AI ambitions by unveiling Meta Compute, accelerating production of its in-house Iris AI chip, and beginning to monetize advanced models like Muse Spark 1.1, alongside appointing longtime marketing leader Alex Schultz as its first chief data officer to tighten data and AI governance. This shift signals Meta’s attempt to convert years of heavy AI infrastructure spending into an enterprise cloud and tooling business, potentially broadening income...

Political shocks can ripple quickly through defense and aerospace stocks, and the sudden death of Senator Lindsey Graham has added a fresh layer of uncertainty around U.S. budget priorities, sanctions, and foreign policy. For investors, that means some companies in this space could see sentiment shift as markets reassess funding expectations, export prospects, and geopolitical risk. This article looks at three stocks from our Defense and Aerospace Stocks screener that appear closely exposed...

Tutor Perini (TPC) is back in focus after a busy stretch of balance sheet moves, including redeeming US$400 million of higher coupon 2029 notes, issuing new 2033 debt, and reshaping its revolving credit facility. See our latest analysis for Tutor Perini. The recent refinancing comes as Tutor Perini’s share price has had a mixed few months, with a 30 day share price return of 1.29% but a share price return over the last 90 days that is down 9.44%. Even so, momentum over longer periods has been...

Tennant (TNC) attracted renewed attention after recent trading left the stock around $85.55, with mixed short term returns and a modest gain over the past 3 months, prompting fresh interest in its valuation profile. See our latest analysis for Tennant. Recent trading has taken place against a backdrop where Tennant’s share price return is up 15.67% year to date and 7.75% over 90 days, while the 1 year total shareholder return of 3.99% points to more muted longer term gains. If you are...